COMPANY
Indee. Inc.
Our patented technology is a robust alternative to electroporation and viral transduction that addresses current industry challenges in cell therapy manufacturing by relieving the bottleneck of the gene transfer step. From company website Source · Oct 13, 2026
NIH awards 5
- NIH award 1R43GM150293-01 FY2023: $295,924 awarded for that fiscal year; activity R43 (SBIR); PI PAWELL, RYAN; recipient as written: INDEE, INC, Berkeley, CA. High efficiency microfluidic device for large scale engin source ↗
- NIH award 1R43DK133029-01 FY2022: $309,636 awarded for that fiscal year; activity R43 (SBIR); PI PAWELL, RYAN; recipient as written: INDEE, INC, Berkeley, CA. Rapid, single-step precision engineering and pre-clinical source ↗
- NIH contract (government contract; not a grant and not an investment round) 75N91022C00053-0-9999-1 FY2022: $1,999,646 awarded for that fiscal year; activity N44 (OTHER_NIH); PI PAWELL, RYAN; recipient as written: INDEE, INC, Berkeley, CA. TOPIC 397 - MICROFLU source ↗
- NIH award 1R43AI155018-01 FY2020: $300,000 awarded for that fiscal year; activity R43 (SBIR); PI JARRELL, JUSTIN ANSEL; recipient as written: INDEE, INC, Berkeley, CA. Integrating microfluidic vortex shedding-mediate source ↗
- NIH contract (government contract; not a grant and not an investment round) 75N91020C00030-0-9999-1 FY2020: $399,299 awarded for that fiscal year; activity N43 (OTHER_NIH); PI JARRELL, JUSTIN; recipient as written: INDEE, INC, Berkeley, CA. Microfluidic vortex source ↗